We found that EMR1-TC was more correlated with CD68+/CD163+ TAMs than with CD3+/CD8+ tumor-infiltrating lymphocytes, and this relationship was more significant in the tumor center than in the tumor-invasive area (data not shown). This evidence concerns the gene CD163 and neoplasm.